5 results
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
RIPE Therapy - Drug ... Microbiologically Confirmed Pulmonary ... #Tuberculosis #ActiveTB ... Therapy #regimens #medications ... #Guidelines #Treatment
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... HIV-AIDS Treating LTBI ... disease) Indications ... no evidence of active ... #IDSA #Prevention
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
tuberculosis (LTBI ... inhibitors • Injection drug ... killed - rest LTBI ... Active TB: • ... : Active TB: •
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
tuberculosis (LTBI ... inhibitors • Injection drug ... killed - rest LTBI ... Active TB: • ... : Active TB: •
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
IDSA Recommendations ... Prophylaxis): Indications ... Note: Active TB ... AviumComplex #MAC #IDSA ... #Prevention #Treatment